Viewing Study NCT00963768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:57 PM
Ignite Modification Date: 2026-03-27 @ 7:28 PM
Study NCT ID: NCT00963768
Status: COMPLETED
Last Update Posted: 2014-04-23
First Post: 2009-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus, Type 2 View
None JNJ-28431754 View
None Canagliflozin View
None Sodium Glucose Co-transporter (SGLT2 inhibitor) View
None Pharmacokinetics View
None Pharmacodynamics View